Esther Yu

Esther Yu, Ph.D., is currently the VP of Regulatory Affairs at Pendulum Therapeutics and serves as an Advisory Board Member at Novoloop. With a Ph.D. from the University of Cambridge, they have held various leadership roles in regulatory sciences and molecular biology, including positions at Zymergen, Corbion, and TerraVia Holdings, Inc. Prior to their current endeavors, Esther worked as a Senior Scientist Project Lead at Solazyme, Inc. and began their career as a Molecular Biology Scientist at Cara Therapeutics.